{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:47:14Z","timestamp":1793832434775,"version":"4.6.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The tumour microenvironment (TME) forms a major obstacle in effective cancer treatment and for clinical success of immunotherapy. Conventional co-cultures have shed light onto multiple aspects of cancer immunobiology, but they are limited by the lack of physiological complexity. We develop a human organotypic skin melanoma culture (OMC) that allows real-time study of host-malignant cell interactions within a multicellular tissue architecture. By co-culturing decellularized dermis with keratinocytes, fibroblasts and immune cells in the presence of melanoma cells, we generate a reconstructed TME that closely resembles tumour growth as observed in human lesions and supports cell survival and function. We demonstrate that the OMC is suitable and outperforms conventional 2D co-cultures for the study of TME-imprinting mechanisms. Within the OMC, we observe the tumour-driven conversion of cDC2s into CD14\n                    <jats:sup>+<\/jats:sup>\n                    DCs, characterized by an immunosuppressive phenotype. The OMC provides a valuable approach to study how a TME affects the immune system.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-16583-0","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T06:05:50Z","timestamp":1591077950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-8277","authenticated-orcid":false,"given":"S.","family":"Di Blasio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. F.","family":"van Wigcheren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-9030","authenticated-orcid":false,"given":"A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-9524","authenticated-orcid":false,"given":"A.","family":"van Duffelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-226X","authenticated-orcid":false,"given":"M.","family":"Gorris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Verrijp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5629-9174","authenticated-orcid":false,"given":"I.","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3602-0014","authenticated-orcid":false,"given":"G. J.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bloemendal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Halilovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-3820","authenticated-orcid":false,"given":"A.","family":"Vasaturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bakdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. V.","family":"Hato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9668","authenticated-orcid":false,"given":"J. H. W.","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8653-4040","authenticated-orcid":false,"given":"I. J. M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-9458","authenticated-orcid":false,"given":"J. C.","family":"Textor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H.","family":"van den Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8112-1773","authenticated-orcid":false,"given":"M.","family":"Tazzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-9212","authenticated-orcid":false,"given":"C. G.","family":"Figdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"16583_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou, W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat. Rev. Cancer 5, 263\u2013274 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"16583_CR2","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt, J. M. et al. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann. Oncol. 27, 1482\u20131492 (2016).","journal-title":"Ann. Oncol."},{"key":"16583_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2015","unstructured":"Klemm, F. & Joyce, J. A. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 25, 198\u2013213 (2015).","journal-title":"Trends Cell Biol."},{"key":"16583_CR4","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1158\/1078-0432.CCR-07-0892","volume":"13","author":"TF Gajewski","year":"2007","unstructured":"Gajewski, T. F. Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment. Clin. Cancer Res. 13, 5256\u20135261 (2007).","journal-title":"Clin. Cancer Res."},{"key":"16583_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molmed.2008.06.001","volume":"14","author":"C Feder-Mengus","year":"2008","unstructured":"Feder-Mengus, C., Ghosh, S., Reschner, A., Martin, I. & Spagnoli, G. C. New dimensions in tumor immunology: what does 3D culture reveal? Trends Mol. Med. 14, 333\u2013340 (2008).","journal-title":"Trends Mol. Med."},{"key":"16583_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fbioe.2016.00012","volume":"4","author":"ME Katt","year":"2016","unstructured":"Katt, M. E., Placone, A. L., Wong, A. D., Xu, Z. S. & Searson, P. C. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front. Bioeng. Biotechnol. 4, 12 (2016).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"16583_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.addr.2014.05.003","volume":"79\u201380","author":"C Hirt","year":"2014","unstructured":"Hirt, C. et al. \u201cIn vitro\u201d 3D models of tumor-immune system interaction. Adv. Drug Deliv. Rev. 79\u201380, 145\u2013154 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"16583_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli, C. et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Disco. 7, 462\u2013477 (2017).","journal-title":"Cancer Disco."},{"key":"16583_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0115-0","volume":"50","author":"Y Choi","year":"2018","unstructured":"Choi, Y. et al. Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. Exp. Mol. Med. 50, 99 (2018).","journal-title":"Exp. Mol. Med."},{"key":"16583_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9440(10)64719-0","volume":"156","author":"F Meier","year":"2000","unstructured":"Meier, F. et al. Human melanoma progression in skin reconstructs: biological significance of bFGF. Am. J. Pathol. 156, 193\u2013200 (2000).","journal-title":"Am. J. Pathol."},{"key":"16583_CR11","doi-asserted-by":"publisher","unstructured":"Li, L., Fukunaga-Kalabis, M. & Herlyn, M. The three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progression. J. Vis. Exp. 2937, https:\/\/doi.org\/10.3791\/2937 (2011).","DOI":"10.3791\/2937"},{"key":"16583_CR12","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","volume":"156","author":"M-Y Hsu","year":"2000","unstructured":"Hsu, M.-Y. et al. E-Cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515\u20131525 (2000).","journal-title":"Am. J. Pathol."},{"key":"16583_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bcp.2014.03.007","volume":"89","author":"DN Syed","year":"2014","unstructured":"Syed, D. N. et al. Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling. Biochem. Pharmacol. 89, 349\u2013360 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"16583_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1023\/B:CLIN.0000006824.41376.b0","volume":"20","author":"P Eves","year":"2003","unstructured":"Eves, P. et al. Melanoma invasion in reconstructed human skin is influenced by skin cells \u2013 investigation of the role of proteolytic enzymes. Clin. Exp. Metastasis 20, 685\u2013700 (2003).","journal-title":"Clin. Exp. Metastasis"},{"key":"16583_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10585-012-9511-3","volume":"30","author":"L Gibot","year":"2012","unstructured":"Gibot, L., Galbraith, T., Huot, J. & Auger, F. A. Development of a tridimensional microvascularized human skin substitute to study melanoma biology. Clin. Exp. Metastasis 30, 83\u201390 (2012).","journal-title":"Clin. Exp. Metastasis"},{"key":"16583_CR16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/CMR.0b013e32833d8d70","volume":"20","author":"JWJ Van Kilsdonk","year":"2010","unstructured":"Van Kilsdonk, J. W. J., Bergers, M., Van Kempen, L. C. L. T., Schalkwijk, J. & Swart, G. W. M. Keratinocytes drive melanoma invasion in a reconstructed skin model. Melanoma Res. 20, 372\u2013380 (2010).","journal-title":"Melanoma Res."},{"key":"16583_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.coi.2010.09.008","volume":"23","author":"Y Ma","year":"2011","unstructured":"Ma, Y., Aymeric, L., Locher, C., Kroemer, G. & Zitvogel, L. The dendritic cell\u2013tumor cross-talk in cancer. Curr. Opin. Immunol. 23, 146\u2013152 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"16583_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.imlet.2009.09.003","volume":"127","author":"A Lin","year":"2010","unstructured":"Lin, A., Schildknecht, A., Nguyen, L. T. & Ohashi, P. S. Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol. Lett. 127, 77\u201384 (2010).","journal-title":"Immunol. Lett."},{"key":"16583_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.it.2013.06.001","volume":"34","author":"E Segura","year":"2013","unstructured":"Segura, E. & Amigorena, S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 34, 440\u2013445 (2013).","journal-title":"Trends Immunol."},{"key":"16583_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","volume":"45","author":"F Veglia","year":"2017","unstructured":"Veglia, F. & Gabrilovich, D. I. Dendritic cells in cancer: the role revisited. Curr. Opin. Immunol. 45, 43\u201351 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"16583_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrc.2016.54","volume":"16","author":"C Engblom","year":"2016","unstructured":"Engblom, C., Pfirschke, C. & Pittet, M. J. The role of myeloid cells in cancer therapies. Nat. Rev. Cancer 16, 447 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"16583_CR22","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.febslet.2014.06.019","volume":"588","author":"J Varga","year":"2014","unstructured":"Varga, J., De Oliveira, T. & Greten, F. R. The architect who never sleeps: tumor-induced plasticity. FEBS Lett. 588, 2422\u20132427 (2014).","journal-title":"FEBS Lett."},{"key":"16583_CR23","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1158\/0008-5472.CAN-15-1695","volume":"76","author":"G Bakdash","year":"2016","unstructured":"Bakdash, G. et al. Expansion of a BDCA1+CD14+ myeloid cell population in melanoma patients may attenuate the efficacy of dendritic cell vaccines. Cancer Res. 76, 4332 (2016).","journal-title":"Cancer Res."},{"key":"16583_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41590-018-0145-8","volume":"19","author":"P Michea","year":"2018","unstructured":"Michea, P. et al. Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific. Nat. Immunol. 19, 885\u2013897 (2018).","journal-title":"Nat. Immunol."},{"key":"16583_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","volume":"38","author":"E Segura","year":"2013","unstructured":"Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336\u2013348 (2013).","journal-title":"Immunity"},{"key":"16583_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/vaccines6030065","volume":"6","author":"TJV Ee","year":"2018","unstructured":"Ee, T. J. V. et al. BDCA1+CD14+ immunosuppressive cells in cancer, a potential target? Vaccines 6, 65 (2018).","journal-title":"Vaccines"},{"key":"16583_CR27","doi-asserted-by":"publisher","first-page":"e23431","DOI":"10.4161\/onci.23431","volume":"2","author":"KF Bol","year":"2013","unstructured":"Bol, K. F., Tel, J., de Vries, I. J. M. & Figdor, C. G. Naturally circulating dendritic cells to vaccinate cancer patients. OncoImmunology 2, e23431 (2013).","journal-title":"OncoImmunology"},{"key":"16583_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0787-6","volume":"7","author":"H Westdorp","year":"2019","unstructured":"Westdorp, H. et al. Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer. J. Immunother. Cancer 7, 302 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"16583_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","volume":"177","author":"M Binnewies","year":"2019","unstructured":"Binnewies, M. et al. Unleashing type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity. Cell 177, 556\u2013571.E16 (2019).","journal-title":"Cell"},{"key":"16583_CR30","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1172\/JCI98060","volume":"128","author":"V Huber","year":"2018","unstructured":"Huber, V. et al. Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma. J. Clin. Invest. 128, 5505\u20135516 (2018).","journal-title":"J. Clin. Invest."},{"key":"16583_CR31","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","volume":"73","author":"Y Mao","year":"2013","unstructured":"Mao, Y. et al. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res. 73, 3877\u20133887 (2013).","journal-title":"Cancer Res."},{"key":"16583_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"16583_CR33","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","volume":"118","author":"N Obermajer","year":"2011","unstructured":"Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P. & Kalinski, P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118, 5498\u20135505 (2011).","journal-title":"Blood"},{"key":"16583_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","volume":"136","author":"F Zhao","year":"2012","unstructured":"Zhao, F. et al. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 136, 176\u2013183 (2012).","journal-title":"Immunology"},{"key":"16583_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood-2005-08-3507","volume":"108","author":"MS von Bergwelt-Baildon","year":"2006","unstructured":"von Bergwelt-Baildon, M. S. et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 108, 228\u2013237 (2006).","journal-title":"Blood"},{"key":"16583_CR36","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1073\/pnas.1516689112","volume":"112","author":"F Weeber","year":"2015","unstructured":"Weeber, F. et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc. Natl Acad. Sci. USA 112, 13308\u201313311 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16583_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945 (2015).","journal-title":"Cell"},{"key":"16583_CR38","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers, H. Modeling development and disease with organoids. Cell 165, 1586\u20131597 (2016).","journal-title":"Cell"},{"key":"16583_CR39","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972\u20131988.e1916 (2018).","journal-title":"Cell"},{"key":"16583_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra, K. K. et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586\u20131598.e1512 (2018).","journal-title":"Cell"},{"key":"16583_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrc3498","volume":"13","author":"M H\u00f6lzel","year":"2013","unstructured":"H\u00f6lzel, M., Bovier, A. & T\u00fcting, T. Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? Nat. Rev. Cancer 13, 365\u2013376 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"16583_CR42","doi-asserted-by":"crossref","unstructured":"Villani, A.-C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","DOI":"10.1126\/science.aah4573"},{"key":"16583_CR43","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1182\/blood-2011-11-392894","volume":"119","author":"J Diao","year":"2012","unstructured":"Diao, J. et al. Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells. Blood 119, 4919\u20134927 (2012).","journal-title":"Blood"},{"key":"16583_CR44","doi-asserted-by":"publisher","first-page":"e1253655","DOI":"10.1080\/2162402X.2016.1253655","volume":"6","author":"L Pyfferoen","year":"2016","unstructured":"Pyfferoen, L. et al. The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome. Oncoimmunology 6, e1253655 (2016).","journal-title":"Oncoimmunology"},{"key":"16583_CR45","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63238-5","volume":"165","author":"G Gerlini","year":"2004","unstructured":"Gerlini, G. et al. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am. J. Pathol. 165, 1853\u20131863 (2004).","journal-title":"Am. J. Pathol."},{"key":"16583_CR46","doi-asserted-by":"publisher","first-page":"e23837","DOI":"10.4161\/onci.23837","volume":"2","author":"JJ Lindenberg","year":"2013","unstructured":"Lindenberg, J. J. et al. Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation. Oncoimmunology 2, e23837 (2013).","journal-title":"Oncoimmunology"},{"key":"16583_CR47","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","volume":"177","author":"FO Martinez","year":"2006","unstructured":"Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303\u20137311 (2006).","journal-title":"J. Immunol."},{"key":"16583_CR48","doi-asserted-by":"publisher","first-page":"642","DOI":"10.4049\/jimmunol.1000413","volume":"185","author":"G Solinas","year":"2010","unstructured":"Solinas, G. et al. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 185, 642\u2013652 (2010).","journal-title":"J. Immunol."},{"key":"16583_CR49","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.cub.2017.06.005","volume":"27","author":"CM Alvey","year":"2017","unstructured":"Alvey, C. M. et al. SIRPA-inhibited, marrow-derived macrophages engorge, accumulate, and differentiate in antibody-targeted regression of solid tumors. Curr. Biol. 27, 2065\u20132077.e6 (2017).","journal-title":"Curr. Biol."},{"key":"16583_CR50","first-page":"375","volume":"24","author":"M Prunieras","year":"1979","unstructured":"Prunieras, M., Regnier, M. & Schlotterer, M. New procedure for culturing human epidermal cells on allogenic or xenogenic skin: preparation of recombined grafts. Ann. Chir. Plast. 24, 375\u2013362 (1979).","journal-title":"Ann. Chir. Plast."},{"key":"16583_CR51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tibtech.2016.03.002","volume":"34","author":"J Rouwkema","year":"2016","unstructured":"Rouwkema, J. & Khademhosseini, A. Vascularization and angiogenesis in tissue engineering: beyond creating static networks. Trends Biotechnol. 34, 733\u2013745 (2016).","journal-title":"Trends Biotechnol."},{"key":"16583_CR52","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/adhm.201600439","volume":"5","author":"MH Mohammadi","year":"2016","unstructured":"Mohammadi, M. H. et al. Skin diseases modeling using combined tissue engineering and microfluidic technologies. Adv. Healthc. Mater. 5, 2459\u20132480 (2016).","journal-title":"Adv. Healthc. Mater."},{"key":"16583_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12015-017-9737-1","volume":"13","author":"LJ van den Broek","year":"2017","unstructured":"van den Broek, L. J., Bergers, L. I. J. C., Reijnders, C. M. A. & Gibbs, S. Progress and future prospectives in skin-on-chip development with emphasis on the use of different cell types and technical challenges. Stem Cell Rev. Rep. 13, 418\u2013429 (2017).","journal-title":"Stem Cell Rev. Rep."},{"key":"16583_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","volume":"8","author":"RW Jenkins","year":"2017","unstructured":"Jenkins, R. W. et al. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer Disco. 8, 196\u2013215 (2017).","journal-title":"Cancer Disco."},{"key":"16583_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/jid.2013.417","volume":"134","author":"EH van den Bogaard","year":"2014","unstructured":"van den Bogaard, E. H. et al. Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases. J. Invest. Dermat. 134, 719\u2013727 (2014).","journal-title":"J. Invest. Dermat."},{"key":"16583_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4049\/jimmunol.1701262","volume":"200","author":"MAJ Gorris","year":"2017","unstructured":"Gorris, M. A. J. et al. Eight-color multiplex immunohistochemistry for simultaneous detection of multiple immune checkpoint molecules within the tumor microenvironment. J. Immunol. 200, 347\u2013354 (2017).","journal-title":"J. Immunol."},{"key":"16583_CR57","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-15-3211","volume":"76","author":"A Vasaturo","year":"2016","unstructured":"Vasaturo, A. et al. T-cell landscape in a primary melanoma predicts the survival of patients with metastatic disease after their treatment with dendritic cell vaccines. Cancer Res. 76, 3496\u20133506 (2016).","journal-title":"Cancer Res."},{"key":"16583_CR58","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16583-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16583-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:45:15Z","timestamp":1670262315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16583-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16583"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16583-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/561530","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"31 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2749"}}